- Company Overview for B&I PHARM LIMITED (13308045)
- Filing history for B&I PHARM LIMITED (13308045)
- People for B&I PHARM LIMITED (13308045)
- Charges for B&I PHARM LIMITED (13308045)
- More for B&I PHARM LIMITED (13308045)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
20 May 2024 | BONA | Bona Vacantia disclaimer | |
18 May 2024 | BONA | Bona Vacantia disclaimer | |
09 May 2023 | GAZ2(A) | Final Gazette dissolved via voluntary strike-off | |
12 Apr 2023 | SOAS(A) | Voluntary strike-off action has been suspended | |
21 Feb 2023 | GAZ1(A) | First Gazette notice for voluntary strike-off | |
09 Feb 2023 | DS01 | Application to strike the company off the register | |
09 Aug 2022 | AA | Accounts for a dormant company made up to 30 April 2022 | |
18 Jul 2022 | MR01 | Registration of charge 133080450001, created on 13 July 2022 | |
01 Jul 2022 | PSC04 | Change of details for Mr Theophilus Ofolie Amesimeku as a person with significant control on 1 July 2022 | |
01 Jul 2022 | PSC04 | Change of details for Mr Benjamin Tuffour as a person with significant control on 1 July 2022 | |
01 Jul 2022 | PSC01 | Notification of Theophilus Ofolie Amesimeku as a person with significant control on 1 July 2022 | |
01 Jul 2022 | AP01 | Appointment of Mr Theophilus Ofolie Amesimeku as a director on 1 July 2022 | |
18 May 2022 | CS01 | Confirmation statement made on 1 March 2022 with updates | |
01 Apr 2021 | NEWINC |
Incorporation
Statement of capital on 2021-04-01
|